Literature DB >> 23895090

Design, synthesis and antimicrobial evaluation of novel 1,3-oxazolidin-2- one derivatives.

Nisha Chandna1, Jitander K Kapoor, Varsha Goyal, Neeraj K Aggarwal, Kotni Meena Kumari, Manga Vijjulatha.   

Abstract

A series of novel derivatives of 1,3-oxazolidin-2-one 12a-12n has been synthesized starting from 4-nitro-(L)- phenylalanine by involving five-step reaction sequence. All the compounds were screened for their in vitro antibacterial activity against four pathogenic bacterial strains namely, Staphylococcus aureus, Bacillus subtilis (Gram-positive), Escherichia coli, Pseudomonas aeruginosa (Gram-negative) and in vitro antifungal activity against two pathogenic fungal strains namely, Candida albicans and Saccharomyces cerevisiae. All the synthesized compounds showed activity against Gram-positive bacteria. Compounds 12c and 12l exhibited maximum antibacterial activity against Gram-positive bacteria. However, against Gram-negative bacteria only five of screened compounds were found to be active. Compounds 12c and 12i displayed best antifungal activity against the tested fungi. Docking studies were carried out in order to gain insight into the mechanism of action and the binding mode of these compounds. These studies were in agreement with the biological data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895090     DOI: 10.2174/15680266113139990132

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  2 in total

1.  Thermodynamic Characterization of Mixed Monolayers of a Novel Oxazolidine Derivative and Phospholipids.

Authors:  Felipe de Sá Rocha; Rafael Ramos da Silva; Gustavo Henrique Ribeiro Codeceira; Maria do Carmo Alves de Lima; Ivan da Rocha Pitta; Maria Danielly Lima de Oliveira; César Augusto Souza de Andrade
Journal:  J Membr Biol       Date:  2018-10-03       Impact factor: 1.843

2.  Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against Candida albicans.

Authors:  Aijaz Ahmad; Mohmmad Younus Wani; Mrudula Patel; Abilio J F N Sobral; Adriano G Duse; Faisal Mohammed Aqlan; Abdullah Saad Al-Bogami
Journal:  Medchemcomm       Date:  2017-10-17       Impact factor: 3.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.